secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76296 grounded facts newest September 1, 2026, 9:26 AM ET RSS · JSON

Showing 4151–4200 of 18629

Appointed

Peter Tassiopoulos

Chief Executive Officer
AIFC · AI Financial Corp
Effective
2024-09-16
Filed
August 30, 2024, 7:59 PM ET
appointed Peter Tassiopoulos to serve as our Chief Executive Officer, effective September 16, 2024
Role change (interim)

Richard Dziadzio

Executive Vice President, Interim Chief Financial Officer and Interim Chief Accounting Officer
Sterling Check Corp.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
In Ms. Strong’s absence, Richard Dziadzio, the Company’s Executive Vice President, Interim Chief Financial Officer, will assume Ms. Strong’s duties as the Company’s principal accounting officer and serve as the Company’s Executive Vice President, Interim Chief Financial Officer and Interim Chief Accounting Officer.
Appointed

Wang Wen Lung

Chief Executive Officer
ANKM · Ankam, Inc.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
The Board of the Company appointed Wang Wen Lung (age 59) as the Chief Executive Officer, Chief Financial Officer, effective on August 28, 2024.
Appointed

Wang Wen Lung

Chief Financial Officer
ANKM · Ankam, Inc.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
The Board of the Company appointed Wang Wen Lung (age 59) as the Chief Executive Officer, Chief Financial Officer, effective on August 28, 2024.
Appointed

Zhenlong Zhao

Chief Executive Officer
TRSO · TRANSUITE.ORG INC.
Effective
2024-08-28
Filed
August 30, 2024, 7:59 PM ET
effective August 28, 2024, Zhenlong Zhao was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.
Appointed

Curt Calaway

Chief Financial Officer
TSN · TYSON FOODS, INC.
Effective
2024-08-29
Filed
August 29, 2024, 7:59 PM ET
On August 29, 2024, Tyson Foods, Inc. (the “Company”) appointed Curt Calaway as the Company’s Chief Financial Officer.
Appointed

Ryan D. Lake

Chief Financial Officer and Secretary
LFCR · LIFECORE BIOMEDICAL, INC. DE
Effective
2024-09-03
Filed
August 29, 2024, 7:59 PM ET
On August 28, 2024, the Company appointed Ryan D. Lake as the Company’s Chief Financial Officer and Secretary, effective September 3, 2024
Departed

John D. Morberg

Chief Financial Officer and Secretary
LFCR · LIFECORE BIOMEDICAL, INC. DE
Effective
2024-09-02
Successor
Ryan D. Lake
Filed
August 29, 2024, 7:59 PM ET
Mr. Morberg's separation will be treated as a termination by the Company without Cause subsequent to a Change in Control under that certain Executive Employment Agreement (the "Morberg Employment Agreement"), dated January 19, 2021, between the Company and Mr. Morberg
Appointed

Preston D. Wigner

Chairman, President and Chief Executive Officer
UVV · UNIVERSAL CORP /VA/
Effective
2024-10-01
Filed
August 29, 2024, 7:59 PM ET
On August 23, 2024, the Board of Directors (the “Board”) of Universal Corporation (the “Company”) named Preston D. Wigner, Senior Vice President, as Chairman of the Board (“Chairman”), President and Chief Executive Officer of the Company, effective October 1, 2024.
Departed

George C. Freeman, III

Chairman, President and Chief Executive Officer
UVV · UNIVERSAL CORP /VA/
Effective
2024-10-01
Successor
Preston D. Wigner
Filed
August 29, 2024, 7:59 PM ET
George C. Freeman, III, who notified the Board of his retirement as Chairman, President and Chief Executive Officer and as a member of the Board on August 23, 2024, with such retirement effective October 1, 2024.
Departed

Brian Di Donato

Chief Financial Officer
IMCR · Immunocore Holdings plc
Effective
2024-12-31
Filed
August 29, 2024, 7:59 PM ET
Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.
Departed

Michael Mason

Executive Vice President, Chief Financial Officer and Treasurer
KPTI · Karyopharm Therapeutics Inc.
Effective
2024-11-05
Filed
August 29, 2024, 7:59 PM ET
On August 26, 2024, Michael Mason notified Karyopharm Therapeutics Inc. (the “Company”) of his intention to resign as the Company’s Executive Vice President, Chief Financial Officer and Treasurer to pursue other professional interests.
Appointed

James Langrock

Chief Financial Officer
FLWS · 1 800 FLOWERS COM INC
Effective
2024-12-29
Filed
August 29, 2024, 7:59 PM ET
James Langrock has been appointed Chief Financial Officer of the Company.
Departed

William E. Shea

Senior Vice President, Treasurer and Chief Financial Officer
FLWS · 1 800 FLOWERS COM INC
Effective
2024-12-29
Successor
James Langrock
Filed
August 29, 2024, 7:59 PM ET
William E. Shea will retire from his position as Senior Vice President, Treasurer and Chief Financial Officer.
Role change

James Creamer

Chief Financial Officer
GBCS · SELECTIS HEALTH, INC.
Effective
2024-08-15
Filed
August 29, 2024, 7:59 PM ET
On August 27, 2024 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) approved the appointment of James Creamer to the position of Chief Financial Officer, effective August 15, 2024.
Appointed

Leif Pedersen

Chief Financial Officer
PIII · P3 Health Partners Inc.
Effective
2024-10-01
Filed
August 29, 2024, 7:59 PM ET
On August 29, 2024, the Board of Directors (the “Board”) of P3 Health Partners Inc. (the “Company”) appointed Leif Pedersen as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).
Departed

Atul Kavthekar

Chief Financial Officer
PIII · P3 Health Partners Inc.
Effective
2024-10-01
Successor
Leif Pedersen
Filed
August 29, 2024, 7:59 PM ET
Mr. Pedersen will succeed Atul Kavthekar, who resigned from his position as Chief Financial Officer of the Company effective as of the Effective Date.
Appointed

Jill Robinson

Executive Vice President, Chief Financial Officer and Treasurer
BATRA · Atlanta Braves Holdings, Inc.
Effective
2024-09-01
Filed
August 29, 2024, 7:59 PM ET
Jill Robinson, age 54, has been appointed Executive Vice President, Chief Financial Officer and Treasurer of the Company.
Appointed

Terence F. McGuirk

President and Chief Executive Officer
BATRA · Atlanta Braves Holdings, Inc.
Effective
2024-09-01
Filed
August 29, 2024, 7:59 PM ET
Terence F. McGuirk, age 73, has been appointed to the role of President and Chief Executive Officer of the Company.
Departed

Michael J. Berry

Executive Vice President and Chief Financial Officer
NTAP · NetApp, Inc.
Effective
2025-05-23
Filed
August 28, 2024, 7:59 PM ET
On August 22, 2024, Michael J. Berry informed the Company of his decision to transition from his role of Executive Vice President and Chief Financial Officer by May 23, 2025.
Departed (interim)

David Rawden

Interim Chief Financial Officer
MEI · METHODE ELECTRONICS INC
Effective
2024-10-01
Successor
Laura Kowalchik
Filed
August 28, 2024, 7:59 PM ET
Ms. Kowalchik will replace David Rawden, who has served as Interim Chief Financial Officer since July 12, 2024.
Appointed

Laura Kowalchik

Chief Financial Officer
MEI · METHODE ELECTRONICS INC
Effective
2024-10-01
Filed
August 28, 2024, 7:59 PM ET
On August 28, 2024, Methode Electronics, Inc. (the “Company”) announced the appointment of Laura Kowalchik as the Company’s Chief Financial Officer, effective October 1, 2024.
Role change (interim)

Scott Boatwright

Interim Chief Executive Officer
CMG · CHIPOTLE MEXICAN GRILL INC
Effective
2024-08-13
Filed
August 28, 2024, 7:59 PM ET
Chipotle’s Board of Directors appointed Scott Boatwright as Interim Chief Executive Officer
Appointed

Adam Rymer

Chief Financial Officer
CMG · CHIPOTLE MEXICAN GRILL INC
Effective
2024-10-01
Filed
August 28, 2024, 7:59 PM ET
advanced the date of Mr. Rymer’s appointment as Chief Financial Officer
Departed

Robert Cook

Chief Financial Officer
CTNT · CHEETAH NET SUPPLY CHAIN SERVICE INC.
Effective
2024-08-30
Successor
Huan Liu
Filed
August 28, 2024, 7:59 PM ET
the Company issued a press release announcing Mr. Cook’s resignation.
Departed

Amy Weaver

President and Chief Financial Officer
CRM · Salesforce, Inc.
Filed
August 28, 2024, 7:59 PM ET
On August 28, 2024, the Company announced that Amy Weaver will step down from her role as President and Chief Financial Officer of the Company effective upon the appointment of her successor or upon the filing of the Company’s annual report on Form 10-K for the fiscal year ending January 31, 2025 (the “10-K Filing Date”), if earlier.
Appointed (interim)

C. Bradford Richmond

Interim Chief Executive Officer
BJRI · BJs RESTAURANTS INC
Effective
2024-08-28
Filed
August 28, 2024, 7:59 PM ET
On August 28, 2024 (the “Effective Date”), BJ’s Restaurants, Inc. (the “Company”) announced that its Board of Directors (the “Board”) approved the appointment of C. Bradford Richmond as Interim Chief Executive Officer of the Company.
Departed

Gregory S. Levin

Chief Executive Officer and President
BJRI · BJs RESTAURANTS INC
Effective
2024-08-28
Successor
C. Bradford Richmond
Filed
August 28, 2024, 7:59 PM ET
On August 28, 2024, the Company announced that effective as of August 28, 2024, Gregory S. Levin would no longer serve as the Company’s Chief Executive Officer and President or as a member of the Board.
Appointed

Garrett L. Chase

Senior Vice President and Chief Financial Officer
VSAT · VIASAT INC
Effective
2024-09-16
Filed
August 28, 2024, 7:59 PM ET
On August 23, 2024, Garrett L. Chase agreed to join Viasat, Inc. (“Viasat”) in the role of Senior Vice President and Chief Financial Officer, effective September 16, 2024.
Appointed

Ran Ziskind

Chief Executive Officer
IR-Med, Inc.
Effective
2024-09-01
Filed
August 28, 2024, 7:59 PM ET
On August 21, 2024, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) appointed Mr. Ran Ziskind to serve as its Chief Executive Officer (CEO), replacing Mr. Ronnie Klein, who had been serving as Interim CEO, effective September 1, 2024.
Departed

John Hartmann

Chief Executive Officer
AAWH · Ascend Wellness Holdings, Inc.
Effective
2024-08-26
Successor
Samuel Brill
Filed
August 28, 2024, 7:59 PM ET
John Hartmann no longer serves as Chief Executive Officer of the Company.
Appointed

Samuel Brill

Chief Executive Officer
AAWH · Ascend Wellness Holdings, Inc.
Effective
2024-08-26
Filed
August 28, 2024, 7:59 PM ET
the Board appointed Samuel Brill as Chief Executive Officer of the Company and removed him as Lead Independent Director of the Board, while maintaining his appointment as director of the Company, effective immediately.
Role change

Marvin S. Hausman

Chief Executive Officer
LUDG · LUDWIG ENTERPRISES, INC.
Effective
2024-08-20
Successor
Jose Antonio Reyes
Filed
August 28, 2024, 7:59 PM ET
Marvin S. Hausman, M.D. resigned as Chief Executive Officer, effective immediately.
Appointed

Jose Antonio Reyes

Chief Executive Officer
LUDG · LUDWIG ENTERPRISES, INC.
Effective
2024-08-20
Filed
August 28, 2024, 7:59 PM ET
the Board appointed a new Chief Executive Officer, Jose Antonio Reyes, effective immediately.
Departed

Jared Demark

chief executive officer (principal executive officer)
BRRR · CoinShares Bitcoin ETF
Effective
2024-08-30
Successor
Jean-Marie Mognetti
Filed
August 28, 2024, 7:59 PM ET
Jared Demark, having provided notice of his resignation, shall cease serving as chief executive officer (principal executive officer) of CoinShares Co. (the “Sponsor”).
Appointed

Jean-Marie Mognetti

principal executive officer
BRRR · CoinShares Bitcoin ETF
Effective
2024-08-30
Filed
August 28, 2024, 7:59 PM ET
Jean-Marie Mognetti will serve as principal executive officer of the Sponsor.
Appointed

William D. Schwartz

Chief Executive Officer
UFPI · UFP INDUSTRIES INC
Effective
2024-12-29
Filed
August 27, 2024, 7:59 PM ET
appointed William D. Schwartz as the Chief Executive Officer (CEO) of the Company, effective December 29, 2024
Departed

Blaise Coleman

President and Chief Executive Officer
Endo LP
Effective
2024-08-29
Successor
Scott Hirsch
Filed
August 27, 2024, 7:59 PM ET
On August 25, 2024, the Board of Directors (the “Board”) of Endo, Inc. (the “Company”) determined that Blaise Coleman will no longer serve as the Company’s President and Chief Executive Officer, effective August 29, 2024.
Appointed (interim)

Scott Hirsch

Interim Chief Executive Officer
Endo LP
Effective
2024-08-29
Filed
August 27, 2024, 7:59 PM ET
The Board has appointed Scott Hirsch, currently a Board member, to serve as the Company’s Interim Chief Executive Officer (“Interim CEO”), effective August 29, 2024.
Departed

Douglas S. Sharp

Executive Vice President of Finance, Chief Financial Officer and Treasurer
NSP · INSPERITY, INC.
Effective
2024-11-15
Successor
James D. Allison
Filed
August 27, 2024, 7:59 PM ET
On August 26, 2024, Douglas S. Sharp notified Insperity, Inc. (“Insperity”) of his decision to retire from Insperity, effective November 15, 2024.
Appointed

James D. Allison

Executive Vice President of Finance, Chief Financial Officer and Treasurer
NSP · INSPERITY, INC.
Effective
2024-11-15
Filed
August 27, 2024, 7:59 PM ET
James D. Allison, age 55, will assume the role of Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of Mr. Sharp’s retirement.
Departed (interim)

Harry Green

Chief Financial Officer
African Agriculture Holdings Inc.
Effective
2024-08-16
Filed
August 27, 2024, 7:59 PM ET
Effective as of August 16, 2024, Harry Green no longer serves as the Chief Financial Officer of African Agriculture Holdings, Inc. (the “Company”).
Departed

Kristi Jones

Chief Executive Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed (interim)

Albert N. Marchio II

Interim Chief Financial Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Appointed

Brett Kaplan

principal financial officer
CLYM · Climb Bio, Inc.
Effective
2024-08-26
Filed
August 27, 2024, 7:59 PM ET
On August 26, 2024, the Board of Directors of the Company (the “Board”) appointed Brett Kaplan, the Company’s Chief Operating Officer, to serve as principal financial officer.
Departed

Don Kalkofen

Chief Financial Officer
ACOG · Alpha Cognition Inc.
Effective
2024-10-01
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Mr. Don Kalkofen tendered his resignation as Chief Financial Officer of Alpha Cognition Inc. (the “Company”), effective October 1, 2024.
Appointed

Kevin Williamson

Chief Financial Officer
TNON · Tenon Medical, Inc.
Effective
2024-09-03
Filed
August 27, 2024, 7:59 PM ET
On August 20, 2024, Tenon Medical, Inc. (the “Company”) entered into an offer letter (the “Letter”) with Kevin Williamson pursuant to which Mr. Williamson was appointed as Chief Financial Officer of the Company, effective as of September 3, 2024.
Appointed

Joseph Ramelli

Chief Financial Officer
FABC · Fabric.AI, Inc.
Effective
2024-08-21
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Ayro, Inc. (the “Company”) appointed Joseph Ramelli to the position of Chief Financial Officer of the Company, effective as August 21, 2024.
Role change

Brian Mitts

Chief Executive Officer
VINEBROOK HOMES TRUST, INC.
Effective
2024-08-26
Successor
John Good
Filed
August 27, 2024, 7:59 PM ET
On August 26, 2024, Brian Mitts resigned from his positions as Chief Executive Officer, Chief Financial Officer, Assistant Secretary and Treasurer of the Company and its subsidiaries. Mr. Mitts will continue to serve as the Company’s President and a member of the Board of Directors of the Company (the “Board”).
Appointed

Paul Richards

Chief Financial Officer
VINEBROOK HOMES TRUST, INC.
Effective
2024-08-26
Filed
August 27, 2024, 7:59 PM ET
the Board also appointed Paul Richards as the Company’s Chief Financial Officer, Assistant Secretary and Treasurer.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.